$3,500.00
GBI Research’s new report, “Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes” provides information and analysis on the m.....
Published: Nov-2012
|
$3,500.00
Leading business intelligence provider GBI Research has released its latest research report, entitled “Drug Discovery and Development Market in Asia - Partnerships Between MNCs, Asian Academic Institu.....
Published: Nov-2012
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research, “Innovation in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency a.....
Published: Sep-2012
|
$3,500.00
GBI Research’s new report, “Accelerating Drugs to Market – Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market”, presents various tools and strategies which c.....
Published: Sep-2012
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research report, “Pathways to Efficient Drug Development - Advances in Modeling and Simulation Outcomes to Fuel Pipeli.....
Published: Sep-2012
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research, “Multi-Targeted Therapies - New Wave of Combination Therapies in Late Stage Development for Lung Cancer Offe.....
Published: Jul-2012
|
$3,500.00
GBI Research, a leading business intelligence provider, has released its latest research, entitled “Epigenetics R&D Pipeline - Histone Deacetylases (HDACs) Offer the Most Promising Targets and Outnumb.....
Published: Jul-2012
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research, “e-Clinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Ac.....
Published: Jul-2012
|